Whether you hope to anticipate and manage new risk in the pursuit of growth, find a seamless global strategy or benchmark your company's pace in responding to change and market pressures, our team can help.
Consult with the best of science and law. The team includes lawyers with higher scientific degrees, many of whom are embedded in industry associations and have experience working as in-house counsel for big pharma, medtech companies and healthcare regulators.
Protecting and Utilizing Your Data in the Life Sciences Ecosystem
Life sciences companies continue to face a myriad of requirements to ensure compliance with a highly regulated industry environment. As businesses innovate in a digital and data-driven world, the interplay between health and data regulations is becoming increasingly complex and challenging.
Explore Data PULSE, a platform that helps you to navigate the complex landscape of data, regulatory and IP protection concerns throughout various stages of the medical product life cycle.
Explore More Resources
|Pricing and Healthcare Access in Latin America
|Chambers Life Sciences Practice Guide 2023|
|Answers questions on pharmaceutical pricing, price controls and access to public and private healthcare||Offers commentary on legal and business issues in major healthcare and life sciences markets|
|Life Sciences Collaborations||Guide to IPOs for Biotech and Pharma Companies|
|Issues to consider in executing life sciences collaborations in the COVID-19 era||An overview of the key considerations at each stage of the IPO process|
|Global Guide to Patent Linkage||Global Medical Cannabis Survey|
|Legal regimes covering patent linkage doctrines and enforcement options for drug patent rights holders||An interactive global dashboard on the import and export rules in over 100 markets. Please contact Lilli Meldrum to request access.|
|Telemedicine and Telehealth Legal Framework Overview||Interacting with Healthcare Professionals|
|Addresses recent developments and future outlook across telemedicine and telehealth, providing guidance on drug distribution and e-pharma||Regulations and traditional practices governing interactions with healthcare professionals (HCPs)|
|Promoting Medical Products Globally||Brexit: Key Implications for the Healthcare and Life Sciences Sector|
|Regulations covering ethical business interactions between medical companies and healthcare professionals||Key areas in the healthcare and life sciences sector impacted by the UK's new trading relationship with EU|
|UAE: Health Data Law||Clinical Trials Handbook|
|Lists the permitted exceptions and conditions to the data transfer restrictions||Legal framework governing clinical trials of medicinal products in 34 jurisdictions|
Healthcare & Life Sciences Supply Chain Series
Focuses on the trends, issues and opportunities along each stage of the supply chain life cycle
FT Big Deal Series: The Healthtech Sector’s Spectacular Surge in SPACs and de-SPACS
A 3-minute video chat on the rise of SPAC investments in the healthtech sector
Biden Supply Chain Policy Video Series: Episode 5 - Pharmaceuticals and Active Pharmaceutical Ingredients
Discusses the impact of the Biden Administration's policies on FDA regulations and government procurement
LSX Masterclass: Partnering & Licensing
Explores how biotech companies can navigate licensing issues and find the right fit for the future
Global Healthcare & Life Sciences Webinar Series
Aims to share legal industry insights and provide practical guidance
The Health Pod
Looks at sector-specific issues and trends
Connect on Tech Podcast Series
Episode 15: Inside the Global Battle for Healthcare Data
Discusses the regulatory restrictions and M&A considerations when protecting healthcare data
Episode 18: Telehealth and COVID-19: US Privacy Changes and Considerations
Updates to US regulations and enforcement priorities that have evolved in response to the pandemic
3R Podcast Series
Episode 10: The Acceleration of Innovation in Healthcare: The Rise of Digital Health Services
Discusses the roles of the government and corporates in fostering innovation in healthcare
Episode 9: Digital Transformation: Analysis Using the SMART Framework
Insights on technology hot topics such as healthtech
Managing the Healthcare & Life Sciences Supply Chain
Learn more about the important considerations at each stage of the supply chain life cycle for healthcare and life sciences companies, including issues which may arise in the areas of M&A, tax, compliance, trade secrets, digital transformation and ESG.
Sustainability Solutions for the Healthcare and Life Sciences Industries
Identifies the key areas driving the shift in sustainability priorities in the sector.
FDA Regulatory Practice
Features our extensive experience in the complex world of products regulated by the FDA, including drugs, medical devices, food, cosmetics, and dietary supplements.
Showcases our multidisciplinary offerings to support clients entering, maintaining and expanding their operations within this fast-growing industry.